Quest for the right Drug

|
עמוד הבית / תרופות חדשות

תרופות חדשות

רופיבקאין אלטן 2 מ"ג/מ"ל ROPIVACAINE ALTAN 2 MG/ML

תאריך רישום: June 27, 2017

מסלול הגשה: תכשיר גנרי

יצרן: ALTAN PHARMACEUTICALS S.A., SPAIN

בעל רישום: PROPHARM LTD

N01BB09 :ATC Code

התוויה

4.1 Therapeutic indications Ropivacaine Altan 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for: Surgical Anaesthesia Lumbar epidural administration for surgery. Ropivacaine Altan 2mg/ml is indicated in adults and adolescents above 12 years of age for: Acute pain management: a. Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain. b. Field blocks. c. Peripheral nerve block via continuous infusion or intermittent bolus injections, e.g. postoperative pain management.

לדף התרופה >

רופיבקאין אלטן 10 מ"ג/מ"ל ROPIVACAINE ALTAN 10 MG/ML

תאריך רישום: June 27, 2017

מסלול הגשה: תכשיר גנרי

יצרן: ALTAN PHARMACEUTICALS S.A., SPAIN

בעל רישום: PROPHARM LTD

N01BB09 :ATC Code

התוויה

4.1 Therapeutic indications Ropivacaine Altan 10 mg/ml is indicated in adults and adolescents aged above 12 years of age for: Surgical Anaesthesia Lumbar epidural administration for surgery. Ropivacaine Altan 2mg/ml is indicated in adults and adolescents above 12 years of age for: Acute pain management: a. Continuous epidural infusion or intermittent bolus administration during postoperative or labour pain. b. Field blocks. c. Peripheral nerve block via continuous infusion or intermittent bolus injections, e.g. postoperative pain management.

לדף התרופה >

גונאל-אף GONAL-F

תאריך רישום: June 7, 2004

מסלול הגשה: מולקולה חדשה

יצרן: MERCK S.L., SPAIN

בעל רישום: MERCK SERONO LTD

G03GA05 :ATC Code

התוויה

4.1 Therapeutic indications In adult women • Anovulation (including polycystic ovarian syndrome) in women who have been unresponsive to treatment with clomiphene citrate. • Stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT). • GONAL-f in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/L In adult men • GONAL-f is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human chorionic gonadotropin (hCG) therapy.

לדף התרופה >

פרימן % 10 PRIMENE 10 %

תאריך רישום: August 2, 2004

מסלול הגשה: מולקולה חדשה

יצרן: BIEFFE MEDITAL S.P.A, ITALY

בעל רישום: REMEDIX CARE LTD

B05XB03 :ATC Code

התוויה

Therapeutic indications that is characterized by the shift of potassium, phosphorus, and magnesium Primene 10% is indicated in 1) children and infants 2) neonates, at term or premature, intracellularly as the patient becomes anabolic. Thiamine deficiency and fluid of normal or low birth weight when oral or enteral nutrition is impossible, insufficient or retention may also develop. Careful monitoring and slowly increasing nutrient intakes contraindicated. while avoiding overfeeding can prevent these complications.

לדף התרופה >

רלקסין RELAXINE

תאריך רישום: June 23, 1999

מסלול הגשה: תכשיר גנרי

יצרן: LABORATOIRES PHARMACEUTIQUES TRENKER SA., GELGIUM

בעל רישום: TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD

:ATC Code

התוויה

לדף התרופה >

רמיטנס 10 RAMITENS 10

תאריך רישום: January 1, 2004

מסלול הגשה: תכשיר גנרי

יצרן: RAFA LABORATORIES LTD., ISRAEL

בעל רישום: RAFA LABORATORIES LTD

C09AA05 :ATC Code

התוויה

לדף התרופה >

חיפושים מובילים לכל התרופות